Subex Reports Q1 Consolidated Net Profit of ₹14.22 Crore Versus ₹12.81 Crore YoY
Subex's Q1 FY27 results highlight a solid performance with revenue rising 19.65% YoY to ₹79.45 crore and net profit increasing 11.01% YoY to ₹14.22 crore. Operationally, normalized EBITDA surged 294.16% YoY to ₹16.87 crore, driven by accelerated backlog conversion and improved execution. The company also approved the implementation of its ESOP 2026 scheme up to 5% of paid-up equity shares.
Market snapshot: Subex Limited has announced its consolidated financial results for the first quarter ended June 30, 2026. The company reported a consolidated net profit of ₹14.22 crore, representing an 11.01% growth year-on-year compared to ₹12.81 crore in the corresponding quarter of the previous fiscal year. Consolidated revenue from operations stood at ₹79.45 crore, up 19.65% year-on-year.
Data Snapshot
- Consolidated Revenue from Operations grew 19.65% YoY to ₹79.45 crore from ₹66.40 crore, and rose 8.9% sequentially from ₹72.96 crore in Q4 FY26.
- Consolidated Net Profit (PAT) increased by 11.01% YoY to ₹14.22 crore from ₹12.81 crore, and grew 43.2% sequentially from ₹9.93 crore in Q4 FY26.
- Normalized EBITDA increased substantially to ₹16.87 crore from ₹4.28 crore in Q1 FY26, showcasing a strong margin improvement to 21.2%.
What's Changed
- Consolidated revenue rose to ₹79.45 crore in Q1 FY27, up 19.65% compared to ₹66.40 crore in Q1 FY26.
- Consolidated net profit grew to ₹14.22 crore from ₹12.81 crore YoY, displaying an 11.01% improvement.
- Normalized EBITDA expanded to ₹16.87 crore (margin of 21.2%) from ₹4.28 crore (margin of 6.45%) YoY.
Key Takeaways
- Strong Topline Momentum: A YoY revenue increase of 19.65% indicates successful deployment of products and monetization of order book.
- Operational Leverage: Normalized EBITDA grew nearly four-fold YoY, highlighting solid cost discipline and execution efficiency.
- Sequential Profit Recovery: PAT rose 43.2% QoQ to ₹14.22 crore compared to ₹9.93 crore in Q4 FY26, illustrating a rebounding trajectory.
- Incentive Alignment via ESOP: Approval of the new ESOP 2026 scheme up to 5% of paid-up equity shares aims to retain and motivate critical talent.
SAHI Perspective
Subex has successfully transitioned into FY27 with a strong footing, demonstrating that its core operational foundation, rebuilt over the past three fiscal years, is yielding results. The major narrative here is the massive expansion in operational margins. Normalized EBITDA margin expanded dramatically to 21.2% from just 6.45% YoY. This indicates that incremental revenues are flowing directly to the bottom line, reflecting significant operating leverage. Although impairment allowances of ₹1.87 crore (up from ₹35 lakh YoY) slightly dragged the bottom line, the underlying business execution remains highly resilient.
Market Implications
The strong Q1 earnings performance is likely to trigger positive sentiment on the stock, which has historically traded under pressure. The massive expansion in operational EBITDA and positive sequential momentum are key signals that the business is turning around. Investors will likely look for sustainability of these margins in upcoming quarters.
Trading Signals
Market Bias: Bullish
Subex has delivered strong Q1 results with a 19.65% YoY revenue growth to ₹79.45 crore and a spectacular four-fold increase in normalized EBITDA to ₹16.87 crore, driven by a 21.2% margin expansion. Sequential profit growth of 43.2% reinforces the operational turnaround.
Overweight: IT Services, Telecom Analytics, AI Software Solutions
Trigger Factors:
- Sustainability of the 21.2% EBITDA margin in Q2 FY27
- Backlog conversion rates and new client logo additions in emerging markets
- Impact of ESOP 2026 on employee cost expenses in the subsequent quarters
Time Horizon: Near-term (0-3 months)
Industry Context
Telecom operators globally are investing heavily in AI-driven fraud management, business assurance, and enterprise asset management to manage risk in digital-first platforms. Subex, with its HyperSense and FraudZap line of offerings, is strategically positioned to capture this demand. The company's recent successful engagements, such as the multi-year deal in North Africa for Enterprise Asset Management and business assurance in the Middle East, show that its product-led turnaround is gaining market traction.
Key Risks to Watch
- Impairment Allowances: Receivables write-offs and impairment provisions remain volatile, rising to ₹1.87 crore in Q1 FY27 from ₹35 lakh YoY.
- Concentration Risk: High dependence on contract renewals and backlog execution from telecom operators in emerging markets like EMEA.
- Human Capital Costs: Rising talent costs and execution of the ESOP 2026 program could pressure operating expenses in future quarters.
Recent Developments
On August 5, 2026, the Board approved the formulation of Subex Employee Stock Option Plan 2026 (ESOP 2026) up to 5% of paid-up equity shares. On July 2, 2026, Subex announced that its 32nd Annual General Meeting was scheduled for August 4, 2026. On February 10, 2026, Subex secured a multi-year agreement with a Tier-1 telecom operator in the Middle East to modernize its Business Assurance capabilities. On March 17, 2026, Subex was chosen by a leading North African telecom operator for a 9-year Enterprise Asset Management engagement valued at approximately EUR 2.7 Million.
Closing Insight
Subex's Q1 FY27 results underscore a fundamental business rehabilitation, where operational efficiency and revenue expansion are finally moving in tandem. While impairment volatility demands monitoring, the overall narrative shifts heavily toward high margin-led profitability.
High Performance Trading with SAHI.
Disclaimer: This news section may include AI-generated or AI-assisted news, summaries, drafts, or insights. All content is subject to human review before publication. While we aim for accuracy, readers should independently verify information before relying on it.
Open Free AccountRelated
JPMorgan Downgrades Apollo Tyres: Navigating Commodity Headwinds and Sector Re-rating
JPMorgan Bullish on TVS Motor: Target Price Hiked to ₹4,440 as Resilience Outshines Sector Risks
JPMorgan Shifts Stance on Escorts Kubota: Upgrade to Neutral Amid Sector Recalibration
Geopolitical Friction in Hormuz: Oil Majors Flag Costs of Proposed Tolls and India’s Readiness Gaps
Recent
Aurobindo Pharma Schedules First Quarter Earnings Call For August 6, 2026
Bikaji Foods Reports Standalone Q1 Net Profit Of ₹64.5 Crore, Approves ₹15 Crore Nepal JV
Cohance Lifesciences Receives FDA 483 With Five Observations For Hyderabad Facility
U.S. Lifts Iran-Related Sanctions, Spurring Hopes For Strait Of Hormuz Reopening
Brigade Enterprises To Review Q1 Results On August 13
Frequently Asked Questions (FAQs)
All topics
Click the link, confirm the box next to sahi.com is checked — ignore any other results.